An in vitro study performed using an isotopic method showed a decrease in susceptibility to chloroquine, quinine, and possibly mefloquine of 44 Plasmodium falciparum isolates collected in and around the city of Conakry in Guinea. Resistance to chloroquine was demonstrated by a mean EC99 at 149 nmol/l, above the cut-off value of 114 nmol/l. The mean EC99 for quinine reached 4,999 nmol/l; that is 5 times higher than that recorded in Gabon. Data collected in Guinea, where for many years drugs have been less readily available than in neighboring countries, do not suggest that drug pressure was essential for selecting resistant parasites.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4269/ajtmh.1987.37.452 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: The treatment and control of malaria in Africa is challenged by drug resistance, including transporter, folate pathway, and PfK13 mutations that mediate resistance to aminoquinolines, antifolates, and artemisinins, respectively. Characterization of drug susceptibility informs optimal control strategies.
Methods: We characterized ex vivo susceptibilities to nine drugs of isolates collected from individuals presenting with uncomplicated falciparum malaria in eastern (2019-2024) and northern (2021-2024) Uganda using a growth inhibition assay and the dihydroartemisinin (DHA) ring survival assay (RSA).
The fight against malaria in Edo-North, Edo State, Nigeria: identifying risk factors for effective control.
PeerJ
December 2024
Department of Mathematical Statistics and Actuarial Sciences, University of the Free State, Bloemfontein, Free State, South Africa.
Background: This study investigated malaria epidemiology in Edo-North, Nigeria; a region within the equatorial rainforest belt that has lacked prior research on malaria prevalence. This research sought to investigate the prevalence of malaria and identify potential risk factors in Edo-North, Nigeria. Additionally, the study aimed to analyze trends in malaria cases to inform the development of effective malaria control measures.
View Article and Find Full Text PDFGlycyrrhizin alleviates the toxicity of hydroxychloroquine in treating oral lichen planus by occupying heat shock protein 90 alpha.
Phytomedicine
December 2024
State Key Laboratory of Oral Diseases & National Center of Stomatology & National Clinical Research Center for Oral Diseases & Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041 Sichuan, China. Electronic address:
Background: Oral lichen planus (OLP) is a common chronic inflammatory disease with the potential of malignant transformation. Hydroxychloroquine (HCQ), derived from quinine originating from Cinchona spp. bark, is a commonly prescribed off-label for OLP.
View Article and Find Full Text PDFA promising class of antiprotozoal agents, design and synthesis of novel Pyrimidine-Cinnamoyl hybrids.
Eur J Med Chem
January 2025
Discipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.
Article Synopsis
- Malaria, mainly caused by Plasmodium protozoans, is a significant global health crisis, particularly in Africa, with rising antimalarial drug resistance prompting the need for new treatments.
- Researchers designed and synthesized a new class of compounds (8a-r) showing promising in vitro activity against the chloroquine-sensitive strain of Plasmodium falciparum, with two compounds (8o and 8l) demonstrating the best efficacy and safety profiles.
- The study also explored the binding affinities of these compounds to essential heat shock proteins in the parasite, suggesting potential targets for combating drug resistance.
Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II genetic cross.
bioRxiv
October 2024
Department of Microbiology & Immunology, Columbia University Irving Medical Center, NY, USA.
The genetic basis of resistance to quinine (QN), a drug used to treat severe malaria, has long been enigmatic. To gain further insight, we used FRG-NOD human liver-chimeric mice to conduct a genetic cross between QN-sensitive and QN-resistant parasites, which also differ in their susceptibility to chloroquine (CQ). By applying different selective conditions to progeny pools prior to cloning, we recovered 120 unique recombinant progeny.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!